Cargando...
Anti-oral Squamous Cell Carcinoma Effects of a Potent TAZ Inhibitor AR-42
Oral squamous cell carcinoma (OSCC) is one of the most common malignancies worldwide. Although great progress has been made in diagnosis and treatment strategies in recent years, the 5-year survival rate of OSCC patients is still disappointingly low. Hence, there is still an unmet medical need for s...
Gardado en:
| Publicado en: | J Cancer |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Ivyspring International Publisher
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6930442/ https://ncbi.nlm.nih.gov/pubmed/31897232 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.32436 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|